Methods of identifying anti-cancer agents and uses thereof

Details Methods of identifying anti-cancer agents and uses thereof Methods of identifying anti-cancer agents and uses thereof

2008-09-15

2010-12-07

Goddard, Laura B (Department: 1642)

Chemistry: molecular biology and microbiology

Animal cell, per se ; composition thereof; process of...

C435S810000

Reexamination Certificate

active

07846723

ABSTRACT:
The present invention provides methods of identifying and/or detecting anti-cancer agents. The present invention provides methods of identifying and/or detecting compounds that can activate PARP and/or induce necrosis. The present invention also provides for methods of treating cancer in an individual. The present invention also provides kits for identifying and/or detecting anti-cancer agents.

REFERENCES:
patent: 7247700 (2007-07-01), Korsmeyer et al.
patent: 2003/0091982 (2003-05-01), Zong et al.
Wei et al (Science, 2001, 292:727-730, IDS).
Zong et al (J of Cell Biology, Jul. 7, 2003, 162:59-69, IDS).
Ochs et al (Cancer Research, 2000, 60:5815-5824).
Lindsten et al (J of Neoruscience, Dec. 3, 2003, 23:11112-11119).
Scorrano et al (Science, Apr. 2003, 300:135-139, IDS).
Adams, J.M. 2003. Ways of dying: multiple pathways to apoptosis. Genes Dev 17: 2481-95.
Baggetto, L.G. 1992. Deviant energetic metabolism of glycolytic cancer cells. Biochimie 74: 959-74.
Burkart, V., Z.Q. Wang, J. Radons, B. Heller, Z. Herceg, L. Stingl, E.F. Wagner, and H. Kolb. 1999. Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozocin. Nat Med 5: 314-9.
Butler, A.P., J.K. Mardian, and D.E. Olins. 1985. Nonhistone chromosomal protein HMG 1 interactions with DNA. Fluorescence and thermal denaturation studies. J Biol Chem 260: 10613-20.
Chabruer, B.A. and D.L. Longo. 2001. Cancer Chemotherapy and Biotherapy: Principles and Practices. In. Lippincott Williams and Wilkins, Philadelphia.
Cheng, E.H., M.C. Wei, S. Weiler, R.A. Flavell, T.W. Mak, T. Lindsten, and S.J. Korsmeyer. 2001. BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol Cell 8: 705-11.
D'Amours, D., S. Desnoyers, I. D'Silva, and G.G. Poirier. 1999. Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. Biochem J 342 ( Pt 2): 249-68.
Degenhardt, K., G. Chen, T. Lindsten, and E. White. 2002a. BAX and BAK mediate p53- independent suppression of tumorigenesis. Cancer Cell 2: 193-203.
Degenhardt, K., R. Sundararajan, T. Lindsten, C. Thompson, and E. White. 2002b. Bax and Bak independently promote cytochrome C release from mitochondria. J Biol Chem 277: 14127-34.
DeVita, V.T. 1997. Principles of Cancer Management: Chemotherapy. In Cancer: Principles and Practice of Oncology (ed. V.T. DeVita, S. Hellman, and S.A. Rosenberg), pp. 333-347. Lippincott-Raven, Philadelphia.
Eaton, S., K. Bartlett, and M. Pourfarzam. 1996. Mammalian mitochondrial beta-oxidation. Biochem J 320 ( Pt 2): 345-57.
Eliasson, M.J., K. Sampei, A.S. Mandir, P.D. Hum, R.J. Traystman, J. Bao, A. Pieper, Z.Q. Wang, T.M. Dawson, S.H. Snyder, and V.L. Dawson. 1997. Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat Med 3: 1089-95.
Evan, G.I. and K.H. Vousden. 2001. Proliferation, cell cycle and apoptosis in cancer. Nature 411: 342-8.
Gonin-Giraud, S., A.L. Mathieu, S. Diocou, M. Tomkowiak, G. Delorme, and J. Marvel. 2002. Decreased glycolytic metabolism contributes to but is not the inducer of apoptosis following IL-3-starvation. Cell Death Differ 9: 1147-57.
Gudkov, A.V. and E.A. Komarova. 2003. The role of p53 in determining sensitivity to radiotherapy. Nat Rev Cancer 3: 117-29.
Ha, H.C. and S.H. Snyder. 1999. Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc Natl Acad Sci U S A 96: 13978-82.
Hartley, A., J.M. Stone, C. Heron, J.M. Cooper, and A.H. Schapira. 1994. Complex I inhibitors induce dose-dependent apoptosis in PC12 cells: relevance to Parkinson's disease. J Neurochem 63: 1987-90.
Holt, J.A. 1983. Cancer, a disease of defective glucose metabolism. Med Hypotheses 10: 133-50.
Jacobson, E.L. and M.K. Jacobson. 1976. Pyridine nucleotide levels as a function of growth in normal and transformed 3T3 cells. Arch Biochem Biophys 175: 627-34.
Kanduc, D., A. Mittelman, R. Serpico, E. Sinigaglia, A.A. Sinha, C. Natale, R. Santacroce, M.G. Di Corcia, A. Lucchese, L. Dini, P. Pani, S. Santacroce, S. Simone, R. Bucci, and E. Farber. 2002. Cell death: apoptosis versus necrosis (review). Int J Oncol 21: 165-70.
Liang, Y., C. Buettger, D.K. Berner, and F.M. Matschinsky. 1997. Chronic effect of fatty acids on insulin release is not through the alteration of glucose metabolism in a pancreatic beta-cell line (beta HC9). Diabetologia 40: 1018-27.
Lindsten, T., A.J. Ross, A. King, W.X. Zong, J.C. Rathmell, H.A. Shiels, E. Ulrich, K.G. Waymire, P. Mahar, K. Frauwirth, Y. Chen, M. Wei, V.M. Eng, D.M. Adelman, M.C. Simon, A. Ma, J.A. Golden, G. Evan, S.J. Korsmeyer, G.R. MacGregor, and C.B. Thompson. 2000. The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol Cell 6: 1389-99.
Lister, T.A. 1991. The management of follicular lymphoma. Ann Oncol 2 Suppl 2: 131-5.
Majno, G. and I. Joris. 1995. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 146: 3-15.
Masutani, M., H. Suzuki, N. Kamada, M. Watanabe, O. Ueda, T. Nozaki, K. Jishage, T. Watanabe, T. Sugimoto, H. Nakagama, T. Ochiya, and T. Sugimura. 1999. Poly(ADP-ribose) polymerase gene disruption conferred mice resistant to streptozotocin-induced diabetes. Proc Natl Acad Sci U S A 96: 2301-4.
Muller, S., P. Scaffidi, B. Degryse, T. Bonaldi, L. Ronfani, A. Agresti, M. Beltrame, and M.E. Bianchi. 2001. New EMBO members' review: the double life of HMGB1 chromatin protein: architectural factor and extracellular signal. Embo J 20: 4337-40.
Myung, P.S., J.L. Clements, D.W. White, Z.A. Malik, J.S. Cowdery, L.H. Allen, J.T. Harty, D.J. Kusner, and G.A. Koretzky. 2000. In vitro and in vivo macrophage function can occur independently of SLP-76. Int Immunol 12: 887-97.
Ohgoh, M., H. Shimizu, H. Ogura, and Y. Nishizawa. 2000. Astroglial trophic support and neuronal cell death: influence of cellular energy level on type of cell death induced by mitochondrial toxin in cultured rat cortical neurons. J Neurochem 75: 925-33.
Pieper, A.A., D.J. Brat, D.K. Krug, C.C. Watkins, A. Gupta, S. Blackshaw, A. Verma, Z.Q. Wang, and S.H. Snyder. 1999a. Poly(ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes. Proc Natl Acad Sci U S A 96: 3059-64.
Pieper, A.A., A. Verma, J. Zhang, and S.H. Snyder. 1999b. Poly (ADP-ribose) polymerase, nitric oxide and cell death. Trends Pharmacol Sci 20: 171-81.
Scaffidi, P., T. Misteli, and M.E. Bianchi. 2002. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418: 191-5.
Scorrano, L., S.A. Oakes, J.T. Opferman, E.H. Cheng, M.D. Sorcinelli, T. Pozzan, and S.J. Korsmeyer. 2003. BAX and BAK regulation of endoplasmic reticulum Ca2+: a control point for apoptosis. Science 300: 135-9.
Shchepina, L.A., E.N. Popova, O.Y. Pletjushkina, and B.V. Chemyak. 2002. Respiration and mitochondrial membrane potential are not required for apoptosis and anti-apoptotic action of Bcl-2 in HeLa cells. Biochemistry (Mosc) 67: 222-6.
Smith, S. 2001. The world according to PARP. Trends Biochem Sci 26: 174-9.
Szabo, C. and V.L. Dawson. 1998. Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. Trends Pharmacol Sci 19: 287-98.
Szabo, C., B. Zingarelli, M. O'Connor, and A.L. Salzman. 1996. DNA strand breakage, activation of poly (ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite. Proc Natl Acad Sci U S A 93: 1753-8.
Tsujimoto, Y., L.R. Finger, J. Yunis, P.C. Nowell, and C.M. Croce. 1984. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science 226: 1097-9.
Vander Heiden, M.G., N.S. Chandel, P.T. Schumacker, and C.B. Thompson. 1999. Bcl-xL prevents cell death following growth factor withdrawal by facilitating mitochondrial ATP/ADP exchange. Mol Cell 3: 159-67.
Vousden, K.H. and X. Lu. 2002. Live or let die: the cell's response to p53. Nat Rev Cancer 2: 594-604.
Wang, X. 2001. The expandi

Affiliated with

Also associated with

Rating

Methods of identifying anti-cancer agents and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of identifying anti-cancer agents and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of identifying anti-cancer agents and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4236113